# Hypertension Monitoring in Glioma Patients Treated With Bevacizumab

> **NCT01046279** · — · TERMINATED · sponsor: **University of Zurich** · enrollment: 40 (actual)

## Conditions studied

- Glioma Patients

## Interventions

- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT01046279
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Problems with enrollement of patients, less patients than expected
- **Last updated:** 2013-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01046279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01046279, "Hypertension Monitoring in Glioma Patients Treated With Bevacizumab". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT01046279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*